Form 4: Co-Diagnostics CFO Reports Stock Transactions
Insider Transaction Report
Co-Diagnostics CFO Brian Lee Brown reports transactions involving restricted stock units and common stock, including a sale to cover tax withholding obligations.
Summary
- Brian Lee Brown, Chief Financial Officer of Co-Diagnostics, Inc. (CODX), has filed a Form 4 detailing transactions related to his beneficial ownership of the company's common stock.
- On May 23, 2026, 3,750 restricted stock units (RSUs) were acquired at a price of $0.00, increasing his total beneficial ownership to 23,729 shares.
- Also on May 23, 2026, 1,350 shares of common stock were disposed of at a price of $5.07 per share, reducing his beneficial ownership to 22,379 shares.
- The disposal of 1,350 shares was to cover tax withholding obligations related to the vesting of RSUs, a transaction mandated by the issuer's equity incentive plans.
- The filing also notes the acquisition of 3,750 restricted stock units on May 23, 2026, with a value of $0.00, bringing the total number of RSUs to 11,250, with 7,500 of these RSUs still held directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine stock transactions for tax purposes and does not indicate significant changes in insider confidence or strategic shifts.
Positives
- The acquisition of 3,750 restricted stock units indicates continued equity-based compensation for the CFO.
- The CFO retains a significant number of RSUs (7,500) and common stock (22,379), suggesting ongoing commitment to the company.
Negatives
- A sale of 1,350 shares was executed to cover tax withholding obligations, which represents a reduction in the CFO's direct holdings.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports past transactions.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company executives and directors. These filings are crucial for investors seeking to understand insider sentiment and potential shifts in beneficial ownership.
Stakeholder Impact
- Shareholders: The filing provides transparency into the CFO's stock holdings and transactions, which can inform investor sentiment. The sale to cover taxes is a routine event and not indicative of a negative outlook on the stock.
- Employees: The continued award of RSUs suggests the company's ongoing use of equity-based compensation to incentivize employees, including management.
- Creditors: No direct impact on creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 05/15/2023 | Date of award for a portion of restricted stock units. |
| 05/23/2026 | Transaction date for acquisition of RSUs and disposal of common stock. |
| 05/27/2026 | Date of signature for the Form 4 filing. |
| 11/23/2023 | Commencement date for vesting of a portion of RSUs awarded on May 15, 2023. |
| 11/23/2024 | Commencement date for vesting of a portion of RSUs awarded on April 26, 2024. |
| 11/23/2025 | Commencement date for vesting of a portion of RSUs awarded on August 13, 2025. |
Keywords
Form 4, SEC Filing, Co-Diagnostics, CODX, Insider Trading, Stock Transaction, Restricted Stock Units, Beneficial Ownership, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.